Unique position of a pancreatic head insulinoma during laparoscopic enucleation: case report
DOI:
https://doi.org/10.18203/2349-2902.isj20203801Keywords:
Insulinoma, Laparoscopy, Pancreatic insulinomaAbstract
Insulinomas are benign pancreatic neuroendocrine tumors that require surgical intervention as a therapeutic measure. We describe an 18-year-old male patient who presented to the emergency department with a history of syncope, blurred vision, and diaphoresis. His blood sugar level was low upon admission, and a 72-hour fasting plasma glucose test showed low serum glucose, high serum insulin, and high C-peptide. An abdominal computed tomography scan and magnetic resonant imaging revealed a solitary tumor in the pancreatic head with no sign of ductal dilatation. Laparoscopic enucleation was performed, and a histopathological examination revealed findings consistent with insulinoma. The patient’s postoperative course was uneventful, and his follow-up examination was unremarkable. In conclusion, physicians should have a high clinical suspicion index for insulinomas, especially in young patients with a history of syncope, blurred vision, and diaphoresis, in order to avoid delayed diagnosis.
References
Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin North Am. 2009;89:1105-21.
Kennedy E, Brody J, Yeo C. Neoplasms of the Endocrine Pancreas. In: Mulholland MW, Lillemoe K, Doherty G, Maier R, Simeone D, Upchurch G, editors. Greenfield’s Surg Sci Princ Pract. Philadelphia, Pa. London: Lippincott Williams & Wilkins. 2010.
Davì MV, Boninsegna L, Dalle Carbonare L, Toaiari M, Capelli P, Scarpa A, et al. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome. Neuroendocrinology. 2011;94:58-65.
Mulholland MW, Doherty GM. Complications in Surgery. 2nd edition. Philadelphia, Pa. London: Lippincott Williams & Wilkins; 2012.
Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P. Pancreatic insufficiency after different resections for benign tumours. Br J Surg. 2008;95:85-91.
Patel S, Narwari M, Parekh D, Shah V. Insulinoma: case report and review of diagnostic and treatment modalities. J Assoc Physicians India. 2013;61:423-6.
Tesfaye N, Seaquist ER. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci. 2010;1212:12-28.
Bouslama K, Maghrebi H, Bedioui H, Bouslama K. L’insulinome pancréatique: approche diagnostique et modalités thérapeutiques. J Afr Hépato-Gastroentérologie. 2014;8:11-5.
Okabayashi T. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19:829.
Lou I, Inabnet WB. Chapter 18-Advances in the diagnosis and management of insulinoma. In: Shifrin AL, editor. Adv Treat Manag Surg Endocrinol. Elsevier; 2020;199-206.
Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol Lond Engl. 2010;6:229-37.
Taye A, Libutti SK. Diagnosis and management of insulinoma: current best practice and ongoing developments. Res. Rep. Endocr. Disord. 2015. Available at: https://www.dovepress.com/diagnosis-and-management-of-insulinoma-current-best-practice-and-ongoi-peer-reviewed-fulltext-article-RRED. Accessed on: 08 January 2020.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95:98-119.